Jackie Hunter

Jackie Hunter stands as a paragon in the realm of pharmaceutical technology and innovation, leveraging the power of artificial intelligence (AI) to revolutionise drug discovery and development. With an illustrious career spanning over four decades, her expertise and leadership have earned her a reputation as a visionary in integrating AI within the pharmaceutical sector. In 2024, Jackie was appointed to the Advisory Board of Digital Science, reflecting her pivotal role in advancing digital and AI technologies. As the Chair of the Board of Biocortex, Stevenage Bioscience Catalyst (SBC) and Brainomix, she continues to spearhead initiatives that harness AI to streamline and enhance bioscience research and clinical practices. Her strategic insights are further recognised through her membership on the Technology Advisory Board of British Petroleum Plc since 2020.

Her career trajectory includes transformative leadership roles such as CEO and Board Director of BenevolentAI, where she directed efforts to utilise AI in expediting drug discovery processes. Jackie’s tenure as CEO of the Biotechnology and Biological Science Research Council underscored her commitment to fostering innovation in biological sciences. Additionally, her early roles at GlaxoSmithKline (GSK), where she advanced from Programme Manager to Senior Vice President and Head of Neurology and GI CEDD, laid the foundation for her expertise in neuropharmacology and biotechnology. These positions enabled her to develop a deep understanding of the complexities and opportunities within the pharmaceutical industry.

Jackie’s contributions have not gone unnoticed. In 2017, Forbes recognised her as one of the Top 20 Women Globally Advancing AI Research, cementing her status as a leading figure in AI-driven pharmaceutical innovation. Her accolades include the Women of Achievement in Science, Engineering & Technology award, the Astra Zeneca Women Pharmacology Prize and her appointment as a Commander of the Order of the British Empire (CBE) for services to the pharmaceutical industry. These honours reflect her unwavering dedication and significant impact on the field.

Her academic roles as a Visiting Professor of Life Sciences at Imperial College London and St George’s Hospital Medical School further demonstrate her dedication to nurturing the next generation of scientists and innovators. As a trustee of the Hertfordshire & Middlesex Wildlife Trust and Chair of the Board of Trustees of The Sainsbury Laboratories, Jackie’s influence extends beyond pharmaceuticals, advocating for environmental sustainability and conservation. Her commitment to education and the environment showcases her holistic approach to scientific and societal advancement.

Jackie Hunter is a sought-after AI keynote speaker for corporate events due to her profound knowledge and pioneering work in AI applications within the pharmaceutical industry. Her extensive experience in leading AI-centric projects and her ability to convey complex technological concepts in an accessible manner make her an invaluable resource for organisations seeking to navigate the future of pharmaceuticals. Her talks often inspire and inform, providing strategic insights on how AI can drive innovation, efficiency and efficacy in drug development and healthcare solutions. In summary, Jackie Hunter’s exceptional career, marked by groundbreaking contributions to pharmaceutical technology and AI, positions her as an authority in the field. Her leadership and visionary approach continue to influence and inspire advancements in the industry, making her a compelling choice for keynote speaking engagements at corporate events focused on the future of pharmaceuticals and AI.